CTOs on the Move

Visus Therapeutics

www.visustx.com

 
Visus Therapeutics is a clinical-stage company in pursuit of developing the world`s first presbyopia-correcting eye drop with the potential to last at least eight hours. With offices in Seattle, Washington, and Orange County, California, our lead clinical candidate is VTI-001 (BRIMOCHOL™), a once-daily eye drop designed to correct the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates.
  • Number of Employees: 25-100
  • Annual Revenue: $500M-1 Billion
  • www.visustx.com
  • 2 Nickerson Street Suite 101
    Seattle, WA USA 98109
  • Phone: 800.281.4536

Executives

Name Title Contact Details

Funding

Visus Therapeutics raised $36M on 03/09/2021

Similar Companies

Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Venture Technology Group

Venture Technology Group is a Farmington Hls, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reditus Laboratories

Reditus Laboratories is a full-service laboratory company. We are committed to providing our client physicians with top-tier, accurate anatomical and clinical pathology services.

Site Management Solutions

Site Management Solutions is a Glen Burnie, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Waltz Pharmacy Inc

Waltz Pharmacy Inc is a Camden, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.